| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Deacetylases | 74 | 2024 | 207 | 12.550 |
Why?
|
| Histone Deacetylase Inhibitors | 33 | 2023 | 218 | 6.400 |
Why?
|
| Cardiomegaly | 35 | 2025 | 174 | 5.690 |
Why?
|
| Myocytes, Cardiac | 41 | 2026 | 546 | 5.560 |
Why?
|
| Heart Failure | 36 | 2026 | 2326 | 5.090 |
Why?
|
| Myocardium | 38 | 2025 | 935 | 4.910 |
Why?
|
| Fibroblasts | 28 | 2026 | 1028 | 3.100 |
Why?
|
| Fibrosis | 21 | 2026 | 561 | 3.060 |
Why?
|
| Ventricular Remodeling | 16 | 2026 | 278 | 2.960 |
Why?
|
| Transcription Factors | 35 | 2026 | 1736 | 2.950 |
Why?
|
| Heart | 18 | 2022 | 626 | 2.770 |
Why?
|
| Nuclear Proteins | 11 | 2026 | 740 | 2.570 |
Why?
|
| Protein Kinase C | 18 | 2015 | 251 | 2.360 |
Why?
|
| Myofibrils | 8 | 2023 | 49 | 1.880 |
Why?
|
| Animals | 146 | 2026 | 38102 | 1.830 |
Why?
|
| Signal Transduction | 54 | 2025 | 5224 | 1.830 |
Why?
|
| Epigenesis, Genetic | 13 | 2025 | 693 | 1.820 |
Why?
|
| Adipocytes | 5 | 2025 | 223 | 1.670 |
Why?
|
| Myofibroblasts | 5 | 2023 | 149 | 1.640 |
Why?
|
| Thermogenesis | 4 | 2025 | 45 | 1.610 |
Why?
|
| Cell Cycle Proteins | 6 | 2026 | 630 | 1.610 |
Why?
|
| Hypertrophy, Right Ventricular | 4 | 2021 | 149 | 1.590 |
Why?
|
| Rats | 49 | 2022 | 5585 | 1.560 |
Why?
|
| Gene Expression Regulation | 34 | 2026 | 2601 | 1.510 |
Why?
|
| Extracellular Matrix | 6 | 2023 | 563 | 1.370 |
Why?
|
| Cells, Cultured | 37 | 2025 | 4151 | 1.370 |
Why?
|
| Chromatin | 10 | 2024 | 553 | 1.350 |
Why?
|
| Mice | 70 | 2026 | 18356 | 1.300 |
Why?
|
| Rats, Sprague-Dawley | 31 | 2021 | 2525 | 1.240 |
Why?
|
| Dual-Specificity Phosphatases | 3 | 2021 | 10 | 1.210 |
Why?
|
| Protein Processing, Post-Translational | 8 | 2023 | 473 | 1.150 |
Why?
|
| Hypertension, Pulmonary | 11 | 2021 | 1957 | 1.120 |
Why?
|
| Azepines | 4 | 2024 | 105 | 1.090 |
Why?
|
| Heart Ventricles | 13 | 2022 | 756 | 1.090 |
Why?
|
| Histones | 13 | 2020 | 666 | 1.090 |
Why?
|
| Angiotensin II | 5 | 2021 | 102 | 1.030 |
Why?
|
| Triazoles | 4 | 2024 | 191 | 1.020 |
Why?
|
| Adipose Tissue | 4 | 2025 | 645 | 0.980 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2024 | 139 | 0.960 |
Why?
|
| Heart-Assist Devices | 3 | 2025 | 568 | 0.950 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2019 | 267 | 0.920 |
Why?
|
| Phosphorylation | 27 | 2023 | 1708 | 0.910 |
Why?
|
| DNA-Binding Proteins | 32 | 2005 | 1482 | 0.880 |
Why?
|
| Hydroxamic Acids | 6 | 2018 | 94 | 0.870 |
Why?
|
| Lysine | 6 | 2022 | 305 | 0.860 |
Why?
|
| Acetylation | 15 | 2020 | 259 | 0.830 |
Why?
|
| Vascular Remodeling | 3 | 2021 | 209 | 0.830 |
Why?
|
| Muscle, Skeletal | 12 | 2023 | 1791 | 0.820 |
Why?
|
| Humans | 109 | 2026 | 145783 | 0.810 |
Why?
|
| Macrophages | 6 | 2026 | 1507 | 0.810 |
Why?
|
| Myocytes, Smooth Muscle | 5 | 2021 | 271 | 0.790 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2024 | 70 | 0.780 |
Why?
|
| Catecholamines | 1 | 2023 | 88 | 0.780 |
Why?
|
| Disease Models, Animal | 24 | 2026 | 4568 | 0.770 |
Why?
|
| Sarcomeres | 3 | 2022 | 97 | 0.770 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2024 | 364 | 0.760 |
Why?
|
| Heart Diseases | 4 | 2021 | 341 | 0.760 |
Why?
|
| Repressor Proteins | 15 | 2019 | 429 | 0.740 |
Why?
|
| Adipose Tissue, Brown | 2 | 2023 | 60 | 0.730 |
Why?
|
| Rejuvenation | 1 | 2022 | 18 | 0.730 |
Why?
|
| Myocardial Infarction | 4 | 2024 | 1211 | 0.720 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2022 | 43 | 0.700 |
Why?
|
| Cell Proliferation | 5 | 2021 | 2514 | 0.690 |
Why?
|
| Assisted Circulation | 1 | 2021 | 26 | 0.690 |
Why?
|
| Heart Murmurs | 1 | 2021 | 14 | 0.670 |
Why?
|
| MEF2 Transcription Factors | 20 | 2020 | 51 | 0.670 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 394 | 0.660 |
Why?
|
| Mice, Inbred C57BL | 22 | 2025 | 5993 | 0.660 |
Why?
|
| Cell Nucleus | 13 | 2015 | 588 | 0.660 |
Why?
|
| Animals, Newborn | 14 | 2017 | 896 | 0.660 |
Why?
|
| Arteries | 1 | 2022 | 261 | 0.640 |
Why?
|
| Epigenomics | 3 | 2021 | 117 | 0.640 |
Why?
|
| Obesity | 4 | 2025 | 3118 | 0.630 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 55 | 0.630 |
Why?
|
| Aortic Diseases | 1 | 2021 | 125 | 0.620 |
Why?
|
| Mice, Knockout | 13 | 2026 | 3130 | 0.620 |
Why?
|
| NF-kappa B | 11 | 2024 | 667 | 0.610 |
Why?
|
| Muscle Proteins | 6 | 2025 | 243 | 0.610 |
Why?
|
| Histone Deacetylase 6 | 6 | 2022 | 17 | 0.610 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2017 | 426 | 0.600 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 12 | 2006 | 165 | 0.590 |
Why?
|
| Pulmonary Artery | 4 | 2021 | 1129 | 0.550 |
Why?
|
| Calcineurin | 12 | 2008 | 105 | 0.550 |
Why?
|
| Cardiovascular Agents | 4 | 2025 | 166 | 0.550 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 101 | 0.550 |
Why?
|
| I-kappa B Proteins | 8 | 2000 | 75 | 0.540 |
Why?
|
| Myogenic Regulatory Factors | 18 | 2009 | 45 | 0.540 |
Why?
|
| T-Lymphocytes | 6 | 2022 | 1998 | 0.530 |
Why?
|
| Drug Discovery | 2 | 2016 | 153 | 0.530 |
Why?
|
| Oxidative Stress | 3 | 2019 | 1360 | 0.510 |
Why?
|
| Models, Biological | 15 | 2022 | 1764 | 0.510 |
Why?
|
| Carrier Proteins | 8 | 2013 | 729 | 0.510 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2019 | 457 | 0.510 |
Why?
|
| Karyopherins | 2 | 2009 | 20 | 0.500 |
Why?
|
| Immunotherapy | 1 | 2022 | 668 | 0.500 |
Why?
|
| Histone Acetyltransferases | 3 | 2014 | 57 | 0.500 |
Why?
|
| Muscle, Smooth, Vascular | 5 | 2021 | 450 | 0.490 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 177 | 0.490 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2017 | 174 | 0.490 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 4 | 2009 | 209 | 0.470 |
Why?
|
| Male | 55 | 2026 | 73011 | 0.460 |
Why?
|
| Blood Pressure | 6 | 2022 | 1782 | 0.460 |
Why?
|
| Protein Binding | 13 | 2019 | 2240 | 0.460 |
Why?
|
| Fatty Liver | 1 | 2018 | 253 | 0.460 |
Why?
|
| Alkaline Phosphatase | 2 | 2017 | 144 | 0.460 |
Why?
|
| Active Transport, Cell Nucleus | 10 | 2010 | 117 | 0.450 |
Why?
|
| Transforming Growth Factor beta | 6 | 2021 | 474 | 0.450 |
Why?
|
| Enzyme Inhibitors | 6 | 2016 | 821 | 0.440 |
Why?
|
| Microtubules | 1 | 2017 | 265 | 0.440 |
Why?
|
| Carbazoles | 1 | 2015 | 53 | 0.430 |
Why?
|
| Transcription, Genetic | 17 | 2014 | 1454 | 0.430 |
Why?
|
| Sumoylation | 1 | 2014 | 16 | 0.430 |
Why?
|
| Receptors, Endothelin | 1 | 2014 | 48 | 0.430 |
Why?
|
| SUMO-1 Protein | 1 | 2014 | 18 | 0.430 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2014 | 40 | 0.420 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 94 | 0.420 |
Why?
|
| MicroRNAs | 4 | 2021 | 686 | 0.420 |
Why?
|
| Pyrroles | 1 | 2015 | 220 | 0.400 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 87 | 0.390 |
Why?
|
| YY1 Transcription Factor | 2 | 2015 | 24 | 0.390 |
Why?
|
| Induced Pluripotent Stem Cells | 5 | 2025 | 273 | 0.380 |
Why?
|
| Phenotype | 9 | 2025 | 3170 | 0.380 |
Why?
|
| Stroke Volume | 6 | 2025 | 655 | 0.370 |
Why?
|
| Calcium | 4 | 2023 | 1191 | 0.370 |
Why?
|
| Transcriptome | 7 | 2025 | 1042 | 0.370 |
Why?
|
| Hydrogels | 4 | 2025 | 701 | 0.360 |
Why?
|
| Myocardial Contraction | 5 | 2023 | 293 | 0.360 |
Why?
|
| Isoenzymes | 7 | 2017 | 295 | 0.360 |
Why?
|
| Enhancer Elements, Genetic | 5 | 2024 | 191 | 0.350 |
Why?
|
| Immunoblotting | 5 | 2014 | 295 | 0.340 |
Why?
|
| Troponin I | 2 | 2023 | 73 | 0.340 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2024 | 108 | 0.330 |
Why?
|
| Myosin Heavy Chains | 4 | 2010 | 183 | 0.320 |
Why?
|
| Cell Culture Techniques | 2 | 2025 | 375 | 0.320 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 499 | 0.320 |
Why?
|
| Proteome | 2 | 2025 | 513 | 0.320 |
Why?
|
| Connectin | 2 | 2022 | 42 | 0.310 |
Why?
|
| Stem Cell Transplantation | 2 | 2021 | 189 | 0.310 |
Why?
|
| Nuclear Localization Signals | 1 | 2010 | 16 | 0.310 |
Why?
|
| Benzamides | 3 | 2019 | 226 | 0.310 |
Why?
|
| Proteomics | 4 | 2025 | 1188 | 0.300 |
Why?
|
| HEK293 Cells | 4 | 2019 | 741 | 0.300 |
Why?
|
| RNA Polymerase II | 3 | 2019 | 350 | 0.300 |
Why?
|
| Cell Line | 17 | 2021 | 2823 | 0.300 |
Why?
|
| COS Cells | 9 | 2010 | 177 | 0.300 |
Why?
|
| Cardiomyopathy, Dilated | 4 | 2025 | 356 | 0.290 |
Why?
|
| Ventricular Function, Left | 3 | 2025 | 544 | 0.290 |
Why?
|
| Protein Isoforms | 4 | 2013 | 399 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2015 | 1166 | 0.280 |
Why?
|
| RNA-Binding Proteins | 3 | 2021 | 447 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2022 | 136 | 0.270 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2010 | 592 | 0.270 |
Why?
|
| Aortic Valve | 3 | 2022 | 364 | 0.270 |
Why?
|
| Tissue Engineering | 2 | 2025 | 438 | 0.270 |
Why?
|
| Cell Differentiation | 9 | 2025 | 2050 | 0.270 |
Why?
|
| Inflammation Mediators | 3 | 2021 | 507 | 0.270 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 335 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 2602 | 0.260 |
Why?
|
| Amino Acid Sequence | 12 | 2016 | 2131 | 0.260 |
Why?
|
| T-Box Domain Proteins | 2 | 2026 | 106 | 0.250 |
Why?
|
| Pyridines | 3 | 2022 | 609 | 0.250 |
Why?
|
| TRPC Cation Channels | 1 | 2006 | 14 | 0.240 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 981 | 0.240 |
Why?
|
| Ankyrins | 2 | 2005 | 11 | 0.240 |
Why?
|
| GATA4 Transcription Factor | 4 | 2020 | 19 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2006 | 443 | 0.220 |
Why?
|
| RNA, Messenger | 9 | 2022 | 2805 | 0.220 |
Why?
|
| Small Molecule Libraries | 2 | 2016 | 111 | 0.220 |
Why?
|
| Gene Regulatory Networks | 2 | 2026 | 318 | 0.220 |
Why?
|
| Acetyltransferases | 2 | 2002 | 27 | 0.220 |
Why?
|
| Protein Kinases | 2 | 2007 | 312 | 0.220 |
Why?
|
| Female | 28 | 2025 | 79045 | 0.220 |
Why?
|
| Citalopram | 1 | 2025 | 32 | 0.220 |
Why?
|
| Cortical Bone | 2 | 2021 | 15 | 0.220 |
Why?
|
| Acylation | 2 | 2022 | 30 | 0.220 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2025 | 40 | 0.220 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 53 | 0.220 |
Why?
|
| Proteins | 4 | 2021 | 1023 | 0.210 |
Why?
|
| Nanotubes, Carbon | 1 | 2025 | 46 | 0.210 |
Why?
|
| Calcium Signaling | 4 | 2015 | 245 | 0.210 |
Why?
|
| Deuterium | 1 | 2025 | 102 | 0.210 |
Why?
|
| 3T3-L1 Cells | 2 | 2022 | 36 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 3 | 2021 | 308 | 0.210 |
Why?
|
| Estrogens | 2 | 2020 | 367 | 0.210 |
Why?
|
| Aging | 2 | 2015 | 1973 | 0.210 |
Why?
|
| Cyclophilins | 1 | 2024 | 40 | 0.210 |
Why?
|
| Hypertension | 3 | 2011 | 1276 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 143 | 0.200 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2021 | 910 | 0.200 |
Why?
|
| Sequence Analysis, RNA | 3 | 2021 | 442 | 0.200 |
Why?
|
| Uncoupling Protein 1 | 1 | 2023 | 17 | 0.200 |
Why?
|
| Mice, Transgenic | 12 | 2023 | 2191 | 0.200 |
Why?
|
| Calcinosis | 2 | 2017 | 234 | 0.200 |
Why?
|
| Autophagy | 2 | 2017 | 291 | 0.200 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2022 | 177 | 0.200 |
Why?
|
| Transcriptional Activation | 7 | 2013 | 372 | 0.200 |
Why?
|
| Adaptation, Physiological | 4 | 2017 | 560 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 979 | 0.190 |
Why?
|
| Diet, High-Fat | 3 | 2022 | 266 | 0.190 |
Why?
|
| Hypoxia | 5 | 2013 | 1199 | 0.190 |
Why?
|
| Genetic Therapy | 1 | 2005 | 316 | 0.190 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 356 | 0.190 |
Why?
|
| Valproic Acid | 2 | 2013 | 49 | 0.190 |
Why?
|
| Enzyme Activation | 6 | 2022 | 762 | 0.180 |
Why?
|
| Cell Communication | 1 | 2024 | 327 | 0.180 |
Why?
|
| Molecular Sequence Data | 13 | 2011 | 2883 | 0.180 |
Why?
|
| Endocardium | 1 | 2022 | 31 | 0.180 |
Why?
|
| Metalloproteases | 1 | 2022 | 42 | 0.180 |
Why?
|
| Acute Kidney Injury | 2 | 2022 | 874 | 0.180 |
Why?
|
| Thiophenes | 1 | 2022 | 117 | 0.180 |
Why?
|
| Cell Physiological Phenomena | 1 | 2002 | 17 | 0.180 |
Why?
|
| NFATC Transcription Factors | 6 | 2006 | 94 | 0.180 |
Why?
|
| Macrophage Activation | 2 | 2021 | 181 | 0.180 |
Why?
|
| Immunohistochemistry | 4 | 2021 | 1723 | 0.180 |
Why?
|
| Matrix Metalloproteinases, Secreted | 1 | 2021 | 12 | 0.180 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2023 | 93 | 0.180 |
Why?
|
| ADAMTS4 Protein | 1 | 2021 | 16 | 0.180 |
Why?
|
| Long Term Adverse Effects | 1 | 2021 | 13 | 0.180 |
Why?
|
| Inflammation | 4 | 2017 | 2884 | 0.180 |
Why?
|
| Menopause | 1 | 2025 | 326 | 0.170 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2001 | 72 | 0.170 |
Why?
|
| Thiazepines | 1 | 2021 | 6 | 0.170 |
Why?
|
| Hemodynamics | 2 | 2018 | 1118 | 0.170 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2022 | 53 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 1043 | 0.170 |
Why?
|
| Homeodomain Proteins | 2 | 2024 | 523 | 0.170 |
Why?
|
| Cellular Senescence | 1 | 2023 | 226 | 0.170 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2021 | 72 | 0.170 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2002 | 414 | 0.170 |
Why?
|
| Paracrine Communication | 1 | 2021 | 67 | 0.170 |
Why?
|
| Structure-Activity Relationship | 6 | 2011 | 563 | 0.170 |
Why?
|
| Biocompatible Materials | 1 | 2025 | 429 | 0.170 |
Why?
|
| Heart Rate | 1 | 2025 | 856 | 0.160 |
Why?
|
| Adenylate Kinase | 3 | 2013 | 26 | 0.160 |
Why?
|
| Naphthyridines | 2 | 2010 | 20 | 0.160 |
Why?
|
| Serine | 5 | 2006 | 143 | 0.160 |
Why?
|
| Microscopy, Fluorescence | 3 | 2009 | 408 | 0.160 |
Why?
|
| Exosomes | 1 | 2021 | 104 | 0.160 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2011 | 196 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2021 | 150 | 0.160 |
Why?
|
| RNA Interference | 2 | 2013 | 475 | 0.160 |
Why?
|
| Histone Deacetylase 2 | 3 | 2013 | 10 | 0.160 |
Why?
|
| Leptin | 1 | 2022 | 248 | 0.160 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2020 | 64 | 0.160 |
Why?
|
| Catalytic Domain | 3 | 2015 | 234 | 0.150 |
Why?
|
| Immunoglobulins | 1 | 2000 | 163 | 0.150 |
Why?
|
| Succinic Acid | 1 | 2019 | 46 | 0.150 |
Why?
|
| Protein Transport | 3 | 2009 | 442 | 0.150 |
Why?
|
| Aminopyridines | 2 | 2010 | 129 | 0.150 |
Why?
|
| Atrial Fibrillation | 1 | 2026 | 558 | 0.150 |
Why?
|
| Diastole | 1 | 2020 | 146 | 0.150 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 23 | 0.150 |
Why?
|
| Ventricular Function | 1 | 2019 | 53 | 0.150 |
Why?
|
| Serum | 1 | 2019 | 58 | 0.150 |
Why?
|
| Biomimetics | 1 | 2019 | 41 | 0.150 |
Why?
|
| Oxadiazoles | 1 | 2019 | 37 | 0.150 |
Why?
|
| Phosphodiesterase 3 Inhibitors | 1 | 2019 | 14 | 0.140 |
Why?
|
| Machine Learning | 1 | 2025 | 587 | 0.140 |
Why?
|
| Reperfusion Injury | 1 | 2022 | 292 | 0.140 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 23 | 0.140 |
Why?
|
| Receptor Cross-Talk | 1 | 2018 | 21 | 0.140 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2019 | 20 | 0.140 |
Why?
|
| Energy Metabolism | 3 | 2022 | 935 | 0.140 |
Why?
|
| Pyrimidines | 2 | 2013 | 530 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2021 | 298 | 0.140 |
Why?
|
| Biopsy | 1 | 2022 | 1082 | 0.140 |
Why?
|
| Wound Healing | 1 | 2021 | 355 | 0.140 |
Why?
|
| Cardiovascular Diseases | 4 | 2025 | 2191 | 0.140 |
Why?
|
| 3' Untranslated Regions | 2 | 2016 | 149 | 0.140 |
Why?
|
| Histone Code | 1 | 2018 | 39 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 264 | 0.140 |
Why?
|
| Metal Nanoparticles | 1 | 2019 | 80 | 0.140 |
Why?
|
| Adipose Tissue, White | 1 | 2018 | 43 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 1 | 2019 | 181 | 0.140 |
Why?
|
| Gold | 1 | 2019 | 116 | 0.140 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 107 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2017 | 1217 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2011 | 638 | 0.130 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 285 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2017 | 7 | 0.130 |
Why?
|
| Amides | 2 | 2009 | 101 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2021 | 3634 | 0.130 |
Why?
|
| 14-3-3 Proteins | 3 | 2010 | 15 | 0.130 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 263 | 0.130 |
Why?
|
| Adenoviridae | 2 | 2011 | 199 | 0.130 |
Why?
|
| Myosins | 1 | 2018 | 132 | 0.130 |
Why?
|
| Feedback, Physiological | 1 | 2017 | 80 | 0.130 |
Why?
|
| Protein Domains | 1 | 2019 | 311 | 0.130 |
Why?
|
| Calcineurin Inhibitors | 3 | 2004 | 69 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 154 | 0.130 |
Why?
|
| Down-Regulation | 2 | 2016 | 618 | 0.130 |
Why?
|
| Middle Aged | 11 | 2025 | 36309 | 0.130 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 153 | 0.130 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2017 | 16 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 4 | 2008 | 196 | 0.130 |
Why?
|
| Synovial Membrane | 2 | 2016 | 124 | 0.130 |
Why?
|
| Human T-lymphotropic virus 1 | 2 | 1996 | 32 | 0.130 |
Why?
|
| Metabolic Syndrome | 1 | 2021 | 361 | 0.130 |
Why?
|
| Lymphocyte Activation | 2 | 2000 | 1133 | 0.120 |
Why?
|
| Kinetics | 5 | 2025 | 1568 | 0.120 |
Why?
|
| Stem Cells | 1 | 2021 | 630 | 0.120 |
Why?
|
| Tissue Scaffolds | 1 | 2019 | 221 | 0.120 |
Why?
|
| Tubulin | 2 | 2015 | 146 | 0.120 |
Why?
|
| Gap Junctions | 1 | 2017 | 67 | 0.120 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2016 | 54 | 0.120 |
Why?
|
| CapZ Actin Capping Protein | 1 | 2016 | 2 | 0.120 |
Why?
|
| Kidney | 2 | 2022 | 1497 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2017 | 334 | 0.120 |
Why?
|
| Synoviocytes | 1 | 2016 | 18 | 0.120 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2016 | 1180 | 0.120 |
Why?
|
| RNA, Long Noncoding | 1 | 2018 | 172 | 0.120 |
Why?
|
| Gene Products, tat | 1 | 1996 | 22 | 0.120 |
Why?
|
| Transcription Initiation Site | 1 | 2016 | 43 | 0.120 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2016 | 24 | 0.120 |
Why?
|
| Cell Movement | 4 | 2015 | 963 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 611 | 0.120 |
Why?
|
| Serum Response Factor | 1 | 2016 | 33 | 0.120 |
Why?
|
| Molecular Imaging | 1 | 2016 | 57 | 0.120 |
Why?
|
| Binding Sites | 6 | 2008 | 1311 | 0.110 |
Why?
|
| Cellular Reprogramming Techniques | 1 | 2015 | 10 | 0.110 |
Why?
|
| Ischemia | 1 | 2019 | 422 | 0.110 |
Why?
|
| Hypertrophy | 3 | 2023 | 128 | 0.110 |
Why?
|
| MyoD Protein | 4 | 2002 | 31 | 0.110 |
Why?
|
| Interleukins | 1 | 2017 | 248 | 0.110 |
Why?
|
| Cell Cycle | 2 | 2019 | 598 | 0.110 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 343 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3418 | 0.110 |
Why?
|
| Osteogenesis | 1 | 2017 | 204 | 0.110 |
Why?
|
| rho-Associated Kinases | 1 | 2015 | 82 | 0.110 |
Why?
|
| Cellular Reprogramming | 1 | 2015 | 98 | 0.110 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 297 | 0.110 |
Why?
|
| Chagas Cardiomyopathy | 1 | 2015 | 27 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 165 | 0.110 |
Why?
|
| Endopeptidases | 1 | 2014 | 80 | 0.100 |
Why?
|
| Biocatalysis | 1 | 2014 | 67 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 5 | 2016 | 1247 | 0.100 |
Why?
|
| Transcription Factor CHOP | 1 | 2014 | 32 | 0.100 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2014 | 29 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 308 | 0.100 |
Why?
|
| Systole | 1 | 2014 | 181 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2017 | 256 | 0.100 |
Why?
|
| Transfection | 8 | 2015 | 927 | 0.100 |
Why?
|
| Physical Exertion | 1 | 2014 | 205 | 0.100 |
Why?
|
| Estrogen Receptor beta | 1 | 2013 | 40 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2015 | 217 | 0.100 |
Why?
|
| Interleukin-1beta | 3 | 2024 | 390 | 0.090 |
Why?
|
| Phosphoproteins | 3 | 2001 | 337 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2013 | 172 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 440 | 0.090 |
Why?
|
| Recombinant Proteins | 7 | 2017 | 1368 | 0.090 |
Why?
|
| Endothelin-1 | 2 | 2011 | 181 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2013 | 154 | 0.090 |
Why?
|
| Endoplasmic Reticulum | 1 | 2014 | 264 | 0.090 |
Why?
|
| Retroviridae Proteins, Oncogenic | 3 | 1997 | 10 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2014 | 322 | 0.090 |
Why?
|
| Protein Biosynthesis | 1 | 2014 | 452 | 0.090 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 2011 | 3 | 0.090 |
Why?
|
| Vascular Diseases | 1 | 2014 | 252 | 0.090 |
Why?
|
| Azoles | 1 | 2011 | 4 | 0.080 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2011 | 45 | 0.080 |
Why?
|
| Cell Size | 2 | 2016 | 93 | 0.080 |
Why?
|
| Materials Testing | 2 | 2025 | 345 | 0.080 |
Why?
|
| Cats | 2 | 2022 | 234 | 0.080 |
Why?
|
| 2,2'-Dipyridyl | 1 | 2010 | 7 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2022 | 2028 | 0.080 |
Why?
|
| Rats, Inbred Dahl | 3 | 2020 | 9 | 0.080 |
Why?
|
| Norepinephrine | 1 | 2011 | 201 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 125 | 0.080 |
Why?
|
| Consensus Sequence | 1 | 2010 | 73 | 0.080 |
Why?
|
| Indoles | 1 | 2014 | 507 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2010 | 331 | 0.080 |
Why?
|
| Molecular Structure | 2 | 2011 | 487 | 0.080 |
Why?
|
| Estradiol | 1 | 2013 | 515 | 0.080 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2005 | 574 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2018 | 1244 | 0.080 |
Why?
|
| Flow Cytometry | 1 | 2013 | 1165 | 0.080 |
Why?
|
| Atrial Natriuretic Factor | 3 | 2004 | 55 | 0.080 |
Why?
|
| Models, Animal | 1 | 2011 | 392 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 514 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 361 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 149 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2010 | 105 | 0.070 |
Why?
|
| Mutation | 6 | 2014 | 4090 | 0.070 |
Why?
|
| Embryo, Mammalian | 3 | 2020 | 234 | 0.070 |
Why?
|
| Cytokines | 2 | 2014 | 2069 | 0.070 |
Why?
|
| Cattle | 4 | 2013 | 946 | 0.070 |
Why?
|
| Heart Defects, Congenital | 1 | 2017 | 910 | 0.070 |
Why?
|
| Cell Survival | 3 | 2015 | 1104 | 0.070 |
Why?
|
| Precipitin Tests | 3 | 2004 | 90 | 0.070 |
Why?
|
| Phenylephrine | 2 | 2021 | 74 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 5 | 2000 | 50 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2020 | 212 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2011 | 260 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2009 | 120 | 0.070 |
Why?
|
| Drug Design | 1 | 2009 | 175 | 0.070 |
Why?
|
| Aged | 5 | 2025 | 26217 | 0.070 |
Why?
|
| Cyclosporine | 2 | 1999 | 256 | 0.070 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 154 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2025 | 848 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 1996 | 625 | 0.070 |
Why?
|
| Swine | 2 | 2021 | 826 | 0.070 |
Why?
|
| Piperazines | 1 | 2010 | 375 | 0.070 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2007 | 28 | 0.070 |
Why?
|
| Adult | 8 | 2019 | 40881 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 668 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2008 | 98 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2006 | 387 | 0.060 |
Why?
|
| Diet | 1 | 2014 | 1278 | 0.060 |
Why?
|
| Apoptosis | 4 | 2021 | 2444 | 0.060 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 193 | 0.060 |
Why?
|
| Rats, Inbred WF | 1 | 2006 | 8 | 0.060 |
Why?
|
| Thiadiazoles | 1 | 2006 | 25 | 0.060 |
Why?
|
| Rats, Inbred SHR | 1 | 2006 | 36 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2000 | 337 | 0.060 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 1 | 2006 | 20 | 0.060 |
Why?
|
| Biological Transport | 2 | 2013 | 424 | 0.060 |
Why?
|
| Cocaine-Related Disorders | 1 | 2007 | 133 | 0.060 |
Why?
|
| Anilides | 1 | 2006 | 84 | 0.060 |
Why?
|
| Models, Genetic | 3 | 2004 | 527 | 0.060 |
Why?
|
| Transcription Factor RelA | 2 | 2024 | 86 | 0.060 |
Why?
|
| SOX9 Transcription Factor | 1 | 2026 | 27 | 0.060 |
Why?
|
| Adenosine Diphosphate | 1 | 2006 | 83 | 0.060 |
Why?
|
| Neurons | 1 | 2015 | 1652 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 855 | 0.060 |
Why?
|
| Kidney Diseases | 1 | 2010 | 426 | 0.060 |
Why?
|
| Gene Deletion | 3 | 2017 | 392 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 8347 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 381 | 0.060 |
Why?
|
| Base Sequence | 6 | 2006 | 2171 | 0.060 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 45 | 0.060 |
Why?
|
| Cyclohexenes | 1 | 2025 | 4 | 0.060 |
Why?
|
| Vinyl Compounds | 1 | 2025 | 5 | 0.060 |
Why?
|
| Pneumonia | 1 | 2011 | 636 | 0.060 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2026 | 83 | 0.060 |
Why?
|
| Models, Anatomic | 1 | 2006 | 87 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2008 | 552 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 372 | 0.060 |
Why?
|
| Heart Atria | 1 | 2026 | 141 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2024 | 19 | 0.050 |
Why?
|
| Fluoresceins | 1 | 2004 | 48 | 0.050 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2025 | 39 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2004 | 44 | 0.050 |
Why?
|
| Research Design | 2 | 2022 | 1139 | 0.050 |
Why?
|
| Injections | 1 | 2025 | 199 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2025 | 148 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 139 | 0.050 |
Why?
|
| Particle Size | 1 | 2025 | 381 | 0.050 |
Why?
|
| Administration, Oral | 3 | 2011 | 867 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2025 | 252 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2015 | 337 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 500 | 0.050 |
Why?
|
| Metabolomics | 2 | 2019 | 733 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2004 | 407 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2000 | 115 | 0.050 |
Why?
|
| Time Factors | 1 | 2014 | 7134 | 0.050 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2023 | 49 | 0.050 |
Why?
|
| Tyrosine | 1 | 2023 | 217 | 0.050 |
Why?
|
| Methylation | 2 | 2019 | 242 | 0.050 |
Why?
|
| Cell Division | 2 | 2002 | 757 | 0.050 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 334 | 0.050 |
Why?
|
| Action Potentials | 2 | 2017 | 502 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2002 | 25 | 0.050 |
Why?
|
| Carbamates | 1 | 2023 | 50 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2023 | 431 | 0.050 |
Why?
|
| Sex Factors | 2 | 2022 | 2110 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 849 | 0.050 |
Why?
|
| Temperature | 1 | 2025 | 633 | 0.040 |
Why?
|
| Gene Expression | 4 | 2016 | 1478 | 0.040 |
Why?
|
| Mice, Obese | 1 | 2022 | 68 | 0.040 |
Why?
|
| Massachusetts | 1 | 2022 | 180 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 2 | 1 | 2001 | 2 | 0.040 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2001 | 11 | 0.040 |
Why?
|
| RNA, Small Nucleolar | 1 | 2021 | 8 | 0.040 |
Why?
|
| Sex Characteristics | 2 | 2019 | 789 | 0.040 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2002 | 130 | 0.040 |
Why?
|
| Rats, Transgenic | 1 | 2021 | 20 | 0.040 |
Why?
|
| Rats, Inbred BN | 1 | 2021 | 56 | 0.040 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2001 | 25 | 0.040 |
Why?
|
| Swine, Miniature | 1 | 2021 | 89 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 2001 | 93 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2015 | 1184 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2004 | 673 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2001 | 191 | 0.040 |
Why?
|
| Muscle Development | 1 | 2001 | 112 | 0.040 |
Why?
|
| Cytoplasm | 3 | 2015 | 254 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2025 | 900 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 358 | 0.040 |
Why?
|
| Culture Media | 1 | 2021 | 161 | 0.040 |
Why?
|
| DNA Primers | 3 | 1996 | 505 | 0.040 |
Why?
|
| Muscle Cells | 2 | 2010 | 41 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 872 | 0.040 |
Why?
|
| Cell Death | 1 | 2002 | 382 | 0.040 |
Why?
|
| Peptides | 1 | 2006 | 999 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2000 | 88 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2025 | 2064 | 0.040 |
Why?
|
| Genes, ras | 1 | 2000 | 96 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2000 | 194 | 0.040 |
Why?
|
| Serotonin | 2 | 2016 | 298 | 0.040 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2019 | 8 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2007 | 1151 | 0.040 |
Why?
|
| Lung | 3 | 2020 | 4116 | 0.040 |
Why?
|
| Pharmacogenomic Testing | 1 | 2019 | 63 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2019 | 247 | 0.030 |
Why?
|
| Pregnancy | 2 | 2022 | 7216 | 0.030 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 1999 | 124 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2019 | 208 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2008 | 387 | 0.030 |
Why?
|
| RNA | 1 | 2004 | 912 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2022 | 765 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2021 | 457 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2019 | 224 | 0.030 |
Why?
|
| Body Weight | 1 | 2022 | 972 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 1505 | 0.030 |
Why?
|
| Autoradiography | 1 | 2017 | 66 | 0.030 |
Why?
|
| Fluorine Radioisotopes | 1 | 2017 | 14 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2000 | 558 | 0.030 |
Why?
|
| Papio | 1 | 2017 | 70 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2017 | 76 | 0.030 |
Why?
|
| Enzyme Repression | 1 | 2016 | 6 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 3 | 2000 | 5 | 0.030 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2016 | 23 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2019 | 420 | 0.030 |
Why?
|
| STAT1 Transcription Factor | 1 | 2016 | 66 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2019 | 615 | 0.030 |
Why?
|
| Antihypertensive Agents | 2 | 2010 | 521 | 0.030 |
Why?
|
| Multienzyme Complexes | 1 | 1996 | 65 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2017 | 205 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2016 | 92 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 1996 | 78 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2004 | 666 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 648 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 690 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 15 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 391 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1997 | 376 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2010 | 1599 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 1996 | 155 | 0.030 |
Why?
|
| Cardiomegaly, Exercise-Induced | 1 | 2014 | 3 | 0.030 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2014 | 17 | 0.030 |
Why?
|
| Clathrin | 1 | 1995 | 26 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2014 | 22 | 0.030 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 37 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2014 | 32 | 0.030 |
Why?
|
| Caseins | 1 | 2014 | 20 | 0.030 |
Why?
|
| Soybean Proteins | 1 | 2014 | 15 | 0.030 |
Why?
|
| Viral Proteins | 1 | 1997 | 350 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 2015 | 39 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 2 | 2008 | 24 | 0.030 |
Why?
|
| Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 157 | 0.030 |
Why?
|
| Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 135 | 0.030 |
Why?
|
| Azetidines | 1 | 2014 | 45 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2015 | 202 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 172 | 0.030 |
Why?
|
| Simvastatin | 1 | 2014 | 59 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 414 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2014 | 93 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1777 | 0.030 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2013 | 16 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 426 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2013 | 43 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 64 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 45 | 0.020 |
Why?
|
| Blood-Retinal Barrier | 1 | 2013 | 13 | 0.020 |
Why?
|
| Calmodulin | 2 | 2006 | 70 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 63 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 106 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2013 | 112 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2014 | 192 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 39 | 0.020 |
Why?
|
| Liver | 1 | 2022 | 1899 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 993 | 0.020 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2013 | 196 | 0.020 |
Why?
|
| Retroviridae | 1 | 1993 | 100 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 209 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 423 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 450 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 85 | 0.020 |
Why?
|
| Sequence Alignment | 2 | 2004 | 362 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 1261 | 0.020 |
Why?
|
| Oncogene Proteins v-rel | 3 | 1997 | 3 | 0.020 |
Why?
|
| Genes, Reporter | 2 | 2004 | 277 | 0.020 |
Why?
|
| Connective Tissue | 1 | 2011 | 38 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-rel | 3 | 1996 | 7 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 1995 | 635 | 0.020 |
Why?
|
| Chick Embryo | 3 | 1997 | 132 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2014 | 1043 | 0.020 |
Why?
|
| Cell Line, Transformed | 2 | 2002 | 138 | 0.020 |
Why?
|
| Aorta, Thoracic | 2 | 2007 | 287 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1995 | 592 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2011 | 91 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1993 | 356 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2014 | 441 | 0.020 |
Why?
|
| Biological Availability | 1 | 2011 | 145 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 365 | 0.020 |
Why?
|
| Retina | 1 | 2013 | 330 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2014 | 409 | 0.020 |
Why?
|
| MADS Domain Proteins | 1 | 2009 | 4 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2011 | 451 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2025 | 11794 | 0.020 |
Why?
|
| Lipids | 1 | 2014 | 707 | 0.020 |
Why?
|
| Colorado | 1 | 2019 | 4556 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 539 | 0.020 |
Why?
|
| Neoplasms | 1 | 2004 | 2913 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2008 | 28 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2008 | 25 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 2399 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2008 | 86 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2007 | 59 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2008 | 172 | 0.020 |
Why?
|
| Brain | 1 | 1999 | 2969 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 2933 | 0.020 |
Why?
|
| Nucleus Accumbens | 1 | 2007 | 135 | 0.010 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2006 | 29 | 0.010 |
Why?
|
| Cocaine | 1 | 2007 | 162 | 0.010 |
Why?
|
| Chickens | 1 | 2006 | 179 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2006 | 273 | 0.010 |
Why?
|
| Reward | 1 | 2007 | 248 | 0.010 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2006 | 130 | 0.010 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2004 | 13 | 0.010 |
Why?
|
| DNA | 2 | 2003 | 1437 | 0.010 |
Why?
|
| Calcium Channels | 1 | 2006 | 157 | 0.010 |
Why?
|
| Receptors, Steroid | 1 | 2004 | 42 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 653 | 0.010 |
Why?
|
| United States | 1 | 2022 | 16126 | 0.010 |
Why?
|
| Thymus Gland | 1 | 2004 | 312 | 0.010 |
Why?
|
| Tritium | 1 | 2003 | 67 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2003 | 45 | 0.010 |
Why?
|
| Ventricular Myosins | 1 | 2003 | 39 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 10091 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2002 | 3 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 2002 | 26 | 0.010 |
Why?
|
| Leucine | 1 | 2003 | 116 | 0.010 |
Why?
|
| Glycogen Synthase Kinases | 1 | 2002 | 3 | 0.010 |
Why?
|
| Emotions | 1 | 2007 | 577 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2002 | 75 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 751 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2008 | 878 | 0.010 |
Why?
|
| Isoproterenol | 1 | 2002 | 96 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2002 | 83 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 1812 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 507 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2001 | 59 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2002 | 141 | 0.010 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2001 | 61 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 2001 | 216 | 0.010 |
Why?
|
| Thyroid Hormones | 1 | 2000 | 69 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2001 | 219 | 0.010 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 2000 | 18 | 0.010 |
Why?
|
| Luciferases | 1 | 2000 | 154 | 0.010 |
Why?
|
| Exons | 1 | 2000 | 364 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 1999 | 43 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2000 | 309 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 1999 | 50 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 277 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 14254 | 0.010 |
Why?
|
| Ligation | 1 | 1999 | 91 | 0.010 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 52 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1999 | 318 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1999 | 335 | 0.010 |
Why?
|
| Testis | 1 | 1999 | 162 | 0.010 |
Why?
|
| Fetus | 1 | 2003 | 804 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 538 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2000 | 680 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2000 | 236 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 1997 | 46 | 0.010 |
Why?
|
| Adolescent | 1 | 2017 | 22577 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1999 | 344 | 0.010 |
Why?
|
| Child | 1 | 2017 | 22740 | 0.010 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 28 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1996 | 81 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 141 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 778 | 0.010 |
Why?
|
| src Homology Domains | 1 | 1996 | 35 | 0.010 |
Why?
|
| Aorta | 1 | 1999 | 441 | 0.010 |
Why?
|
| Gene Products, tax | 1 | 1995 | 15 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 887 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1995 | 156 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1995 | 45 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1995 | 376 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2000 | 675 | 0.010 |
Why?
|
| Transcription Factor RelB | 1 | 1993 | 3 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 1993 | 23 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1999 | 1491 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1996 | 697 | 0.010 |
Why?
|
| Antibodies | 1 | 1995 | 397 | 0.010 |
Why?
|
| Birds | 1 | 1993 | 86 | 0.010 |
Why?
|
| Spleen | 1 | 1993 | 508 | 0.010 |
Why?
|
| HIV-1 | 1 | 1995 | 908 | 0.000 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 1993 | 1450 | 0.000 |
Why?
|